OncoSil Medical Limited (ASX:OSL)
0.0040
0.00 (0.00%)
Apr 4, 2025, 3:36 PM AEST
OncoSil Medical Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 8.47 | 4.5 | 9.39 | 11.28 | 12.24 | 21 | Upgrade
|
Cash & Short-Term Investments | 8.47 | 4.5 | 9.39 | 11.28 | 12.24 | 21 | Upgrade
|
Cash Growth | 73.06% | -52.08% | -16.72% | -7.84% | -41.71% | 173.08% | Upgrade
|
Accounts Receivable | 0.41 | 1.36 | 1.16 | 0.85 | 1.11 | 2.76 | Upgrade
|
Other Receivables | 1.61 | 0.07 | 0.12 | 0.06 | 0.08 | 0.04 | Upgrade
|
Receivables | 2.01 | 1.44 | 1.29 | 0.91 | 1.18 | 2.81 | Upgrade
|
Prepaid Expenses | - | 0.39 | 0.44 | 0.47 | 0.11 | 0.05 | Upgrade
|
Other Current Assets | 0.59 | - | 0.12 | 0.09 | 0.09 | 0.07 | Upgrade
|
Total Current Assets | 11.07 | 6.33 | 11.23 | 12.74 | 13.62 | 23.92 | Upgrade
|
Property, Plant & Equipment | 0.43 | 0.39 | 0.24 | 0.32 | 0.53 | 0.14 | Upgrade
|
Total Assets | 11.5 | 6.72 | 11.47 | 13.07 | 14.15 | 24.06 | Upgrade
|
Accounts Payable | 2.28 | 1.12 | 0.96 | 0.93 | 1.23 | 1.36 | Upgrade
|
Accrued Expenses | 0.44 | 0.34 | 0.16 | 0.34 | 0.51 | 0.48 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 0.03 | Upgrade
|
Current Portion of Leases | 0.03 | 0.03 | 0.15 | 0.17 | 0.16 | 0.08 | Upgrade
|
Other Current Liabilities | 0.14 | 0.45 | 0.3 | 0.33 | 0.23 | 0.21 | Upgrade
|
Total Current Liabilities | 2.9 | 1.94 | 1.57 | 1.77 | 2.13 | 2.16 | Upgrade
|
Long-Term Leases | 0.04 | 0.04 | 0.02 | 0.14 | 0.32 | - | Upgrade
|
Total Liabilities | 2.94 | 1.98 | 1.59 | 1.91 | 2.45 | 2.16 | Upgrade
|
Common Stock | 94.94 | 90.09 | 86.51 | 79.91 | 70.4 | 70.14 | Upgrade
|
Retained Earnings | -99.47 | -92.78 | -84.37 | -73.02 | -62.3 | -51.86 | Upgrade
|
Comprehensive Income & Other | 13.1 | 7.42 | 7.74 | 4.28 | 3.6 | 3.63 | Upgrade
|
Shareholders' Equity | 8.56 | 4.74 | 9.88 | 11.16 | 11.7 | 21.9 | Upgrade
|
Total Liabilities & Equity | 11.5 | 6.72 | 11.47 | 13.07 | 14.15 | 24.06 | Upgrade
|
Total Debt | 0.07 | 0.07 | 0.17 | 0.3 | 0.48 | 0.11 | Upgrade
|
Net Cash (Debt) | 8.4 | 4.43 | 9.22 | 10.98 | 11.76 | 20.89 | Upgrade
|
Net Cash Growth | 75.46% | -51.96% | -15.97% | -6.63% | -43.72% | 171.65% | Upgrade
|
Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
Filing Date Shares Outstanding | 4,607 | 3,332 | 1,976 | 991.24 | 797.34 | 828.6 | Upgrade
|
Total Common Shares Outstanding | 4,607 | 3,332 | 1,976 | 991.24 | 797.34 | 828.6 | Upgrade
|
Working Capital | 8.17 | 4.39 | 9.67 | 10.98 | 11.49 | 21.76 | Upgrade
|
Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
Tangible Book Value | 8.56 | 4.74 | 9.88 | 11.16 | 11.7 | 21.9 | Upgrade
|
Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade
|
Machinery | 0.09 | 0.1 | 0.12 | - | - | - | Upgrade
|
Construction In Progress | 0.33 | 0.33 | 0.06 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.